Drug details
Rezulin (troglitazone (removed from the us market 3/21/00))
type of Antidiabetics, Thiazolidinediones
Rezulin (troglitazone) is an oral antihyperglycemic agent used to help those with type 2 diabetes respond better to insulin and to reduce the amount of sugar produced by the liver. Rezulin is no longer available in the United States. Rezulin (troglitazone) may still be available in generic form.
The drug is often used to treat Type 2 diabetes .
This drug may have the following side effects:
- dizziness
- diarrhea
- runny or stuffy nose
- headache
- swelling of the extremities
- weakness
- infection
- urinary tract infection
- back pain, and sore throat.